A DOUBLE-BLIND, RANDOMISED, PLACEBO (PL)-CONTROLLED, PHASE 2B STUDY EVALUATING FIRST-LINE USE OF SORAFENIB (SOR) IN COMBINATION WITH PACLITAXEL (PAC) IN PATIENTS (PTS) WITH ADVANCED BREAST CANCER (BC)
ANNALS OF ONCOLOGY（2010）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined